Lsv Asset Management Stake in Johnson & Johnson (JNJ) Cut by $28.02 Million as Valuation Rose

February 20, 2018 - By Darrin Black

Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It has no change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Strategic Wealth Advsr Gp Ltd Liability Corp holds 0.56% or 26,387 shares. Alliancebernstein LP has invested 1.01% in Johnson & Johnson (NYSE:JNJ). Sawgrass Asset Mngmt Ltd Limited Liability Company holds 2.55% or 401,359 shares. Chilton Llc owns 0.07% invested in Johnson & Johnson (NYSE:JNJ) for 13,800 shares. Mycio Wealth Limited Liability Corp reported 35,892 shares. Whalerock Point Prns Lc reported 2.16% in Johnson & Johnson (NYSE:JNJ). Community Fincl Bank Na holds 82,138 shares. United Asset Strategies accumulated 5,574 shares. Bainco Invsts accumulated 185,982 shares or 2.89% of the stock. Private Cap Advsr Inc holds 9,833 shares or 0.44% of its portfolio. Old Second State Bank Of Aurora reported 41,472 shares. Curbstone Financial Corporation has invested 1.14% in Johnson & Johnson (NYSE:JNJ). Corda Inv Mngmt Lc stated it has 3.48% of its portfolio in Johnson & Johnson (NYSE:JNJ). Jfs Wealth Ltd Llc stated it has 0.82% of its portfolio in Johnson & Johnson (NYSE:JNJ). Blackrock reported 1.1% in Johnson & Johnson (NYSE:JNJ).

Lsv Asset Management decreased its stake in Johnson & Johnson (JNJ) by 2.15% based on its latest 2017Q3 regulatory filing with the SEC. Lsv Asset Management sold 215,526 shares as the company’s stock rose 6.85% with the market. The institutional investor held 9.82M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.28B, down from 10.03 million at the end of the previous reported quarter. Lsv Asset Management who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $357.71 billion market cap company. The stock increased 1.46% or $1.92 during the last trading session, reaching $133.15. About 7.97M shares traded or 6.53% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since February 20, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Lsv Asset Management, which manages about $82.68B and $60.63 billion US Long portfolio, upped its stake in Old National Bancorp (NASDAQ:ONB) by 323,054 shares to 1.45M shares, valued at $26.49 million in 2017Q3, according to the filing. It also increased its holding in Bloomin’ Brands Inc. (NASDAQ:BLMN) by 1.05M shares in the quarter, for a total of 3.03 million shares, and has risen its stake in Citrix Systems Inc. (NASDAQ:CTXS).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Your Daily Pharma Scoop: AbbVie’s Upadacitinib, Johnson & Johnson’s Tremfya …” on February 19, 2018, also Cnbc.com with their article: “Johnson & Johnson falls on ‘disappointing’ sales outlook” published on January 23, 2018, Fool.com published: “The case for Johnson & Johnson” on February 13, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Cnbc.com and their article: “Johnson & Johnson falls on report that lawsuits could expose potentially …” published on February 05, 2018 as well as Bizjournals.com‘s news article titled: “Berko: Johnson & Johnson has a bright future (and talcum powder is safe)” with publication date: February 19, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $137.72’s average target is 3.43% above currents $133.15 stock price. Johnson & Johnson had 89 analyst reports since August 7, 2015 according to SRatingsIntel. Barclays Capital upgraded Johnson & Johnson (NYSE:JNJ) on Tuesday, December 1 to “Overweight” rating. On Friday, October 6 the stock rating was maintained by Cowen & Co with “Buy”. Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, June 14. Jefferies has “Hold” rating and $109 target. Citigroup initiated the shares of JNJ in report on Monday, September 25 with “Hold” rating. On Tuesday, November 29 the stock rating was downgraded by Barclays Capital to “Equal-Weight”. As per Friday, July 21, the company rating was downgraded by Alembic. The company was upgraded on Monday, March 14 by Goldman Sachs. UBS maintained it with “Buy” rating and $144.0 target in Wednesday, October 19 report. The rating was maintained by Jefferies with “Hold” on Thursday, July 14. S&P Research maintained it with “Buy” rating and $120 target in Wednesday, October 14 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: